DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Weidmann E, Hess G, Krause SW. et al.
Combination Chemoimmunotherapy using alemtuzumab, fludarabine, cyclophosphamide, and doxorubicine (Campath-FCD) is an effective first-line regimen in peripheral T-cell lymphomas.
Blood 2004; 104 (Supplement) #2640-#2640
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.